Sign in
4

Changes in Ownership

Aquestive Therapeutics, Inc. Filed Acc 0001214659-20-007366

SVP-Chief Financial Officer sold 3,000 shares at $8.00 ($24,000)

From the SEC's structured data for this filing

Trades in this filing

Maxwell John T. · SVP-Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-08-18 Sale : show line 1 in the form −3,000 $8.00 $24,000 150,614 D
Open-market sales · 3,000 sh · avg $8.00 · $24,000
Loading xslF345X03/marketforms-49485.xml…